A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers
Conditions:   Microsatellite High Cancers;   Peritoneal Mesothelioma;   Extrapulmonary High Grade;   Neuroendocrine Carcinomas;   Cervical Carcinoma;   Hodgkin's Lymphoma;   Pleural Mesothelioma;   Small Cell Lung Cancer Intervention:   Drug: XmAb20717 Sponsor:   M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 20, 2022 Category: Research Source Type: clinical trials

A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)
Condition:   Mesothelioma, Malignant Intervention:   Sponsor:   Bristol-Myers Squibb Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2022 Category: Research Source Type: clinical trials